2024-04-03 21:51:51 ET
Summary
- Teradyne's balance sheet is strong, with a high cash position and no debt, but its top line and profitability have declined in recent years.
- A recovery in all the segments of the business should help the company, but I need to see those numbers come through first.
- Teradyne's margins and efficiency have also declined, and it is losing its competitive edge in the semiconductor industry.
- Even with the assumptions that the management provided, the company seems overvalued.
Introduction
Read the full article on Seeking Alpha
For further details see:
Teradyne: Overvalued And Not Enough Improvements To Entice Me